1 Top Dividend Stock to Buy Right Now
The pharmaceutical industry is an excellent place to look for dividend stocks. Since no one can predict illnesses in advance -- or the timing of the need for lifesaving medicines -- the demand for the drugs that pharma companies offer remains relatively constant regardless of economic conditions.
That's why prominent pharma giants have stable, reliable businesses that generate recurrent profits and stable cash flows, all of which are essential to sustain dividend growth. Let's examine one pharma company that looks like an outstanding dividend stock to buy right now: Novartis (NYSE: NVS).
Novartis is perhaps best-known for its portfolio of cancer medicines, but the company's lineup is well-diversified across many other pharmaceutical areas. Within its oncology division, it markets medicines such as Tasigna, Promacta (sold as Revolade outside the U.S.), and Jakavi. Note that the latter is marketed by Incyte in the U.S., and Novartis pays royalties to Incyte for sales of Jakavi in Europe.
Source Fool.com
